Transcript
Page 1: Ian Seppelt: ICU in Review

“Less is More”Advances in Intensive Care in

2012Dr Ian Seppelt

Dept of Intensive Care Medicine, Nepean Hospital,

and George Institute for Global Health,

Page 2: Ian Seppelt: ICU in Review

A personal view of 2012

1. New intensive care literature and publications

2. New approaches to research methodology

3. New advances in (lack of) research ethics

Page 3: Ian Seppelt: ICU in Review

A personal view of 2012

1. New intensive care literature and publications

2. New approaches to research methodology

3. New advances in (lack of) research ethics

Less is more – Don’t just do something, stand there!

Page 4: Ian Seppelt: ICU in Review

A personal view of 2012

1. New intensive care literature and publications

2. New approaches to research methodology

3. New advances in (lack of) research ethics

Less is more – Don’t just do something, stand there!

Law 13: The delivery of good medical care is to do as much Nothing as possible

– The Fat Man

Page 5: Ian Seppelt: ICU in Review

Perner: New Engl J Med 2012

Page 6: Ian Seppelt: ICU in Review

Perner: New Engl J Med 2012

Page 7: Ian Seppelt: ICU in Review

Perner: New Engl J Med 2012

Page 8: Ian Seppelt: ICU in Review

Perner: New Engl J Med 2012

Page 9: Ian Seppelt: ICU in Review
Page 10: Ian Seppelt: ICU in Review
Page 11: Ian Seppelt: ICU in Review

Updated systematic review: mortality

Gattas: Under review

Page 12: Ian Seppelt: ICU in Review

Updated systematic review: RRT

Gattas: Under review

Page 13: Ian Seppelt: ICU in Review
Page 14: Ian Seppelt: ICU in Review
Page 15: Ian Seppelt: ICU in Review
Page 16: Ian Seppelt: ICU in Review
Page 17: Ian Seppelt: ICU in Review
Page 18: Ian Seppelt: ICU in Review
Page 19: Ian Seppelt: ICU in Review

`

Page 20: Ian Seppelt: ICU in Review

`

Page 21: Ian Seppelt: ICU in Review

Research Fraud - Joachim Boldt

German Medical Board Issues Sweeping Findings in Boldt CaseNinety studies implicated in probe, might require retractionby Adam Marcus

Unglaublich is the German word for unbelievable, and it's an apt description for the latest development in the case of Joachim Boldt,  MD, PhD. Dr. Boldt, a prominent German anesthesiologist, has been at the center of a research and publishing scandal since last October, when the journal Anesthesia & Analgesia retracted a 2009 article of his over concerns of data manipulation.

Page 22: Ian Seppelt: ICU in Review

2012 – A new record

Page 23: Ian Seppelt: ICU in Review

2012 – A new record

Page 24: Ian Seppelt: ICU in Review

2012 – A new record

Page 25: Ian Seppelt: ICU in Review

2012 – A new recordThe top 4 clinical

research frauds are all anaesthetists, intensivists

or perioperative physicians

Page 26: Ian Seppelt: ICU in Review

2012 – A new recordThe top 4 clinical

research frauds are all anaesthetists, intensivists

or perioperative physicians

Page 27: Ian Seppelt: ICU in Review

2012 – A new recordThe top 4 clinical

research frauds are all anaesthetists, intensivists

or perioperative physicians

1. YoshitakaFuji

Page 28: Ian Seppelt: ICU in Review

Research Integrity

Page 29: Ian Seppelt: ICU in Review

Research Integrity

Page 30: Ian Seppelt: ICU in Review

Research Integrity

1. CHEST – Prespecified and

published protocol and statistical analysis plan

– Should now be standard

Page 31: Ian Seppelt: ICU in Review

Research Integrity

1. CHEST – Prespecified and

published protocol and statistical analysis plan

– Should now be standard

2. 6S– Writing committee

blinded until after results section and

Page 32: Ian Seppelt: ICU in Review

Research Integrity

1. CHEST – Prespecified and

published protocol and statistical analysis plan

– Should now be standard

2. 6S– Writing committee

blinded until after results section and

Page 33: Ian Seppelt: ICU in Review

Research Integrity

1. CHEST – Prespecified and

published protocol and statistical analysis plan

– Should now be standard

2. 6S– Writing committee

blinded until after results section and

Page 34: Ian Seppelt: ICU in Review

Where next? Choice of fluid?

Page 35: Ian Seppelt: ICU in Review

Where next? Choice of fluid?

Page 36: Ian Seppelt: ICU in Review

NHMRC funding announced Oct 18th, 2012 $2,384,173.35

Where next? Fluid restriction?

Page 37: Ian Seppelt: ICU in Review
Page 38: Ian Seppelt: ICU in Review

ARDS

Page 39: Ian Seppelt: ICU in Review

ARDS

Page 40: Ian Seppelt: ICU in Review
Page 41: Ian Seppelt: ICU in Review

Results

Page 42: Ian Seppelt: ICU in Review

Results

Page 43: Ian Seppelt: ICU in Review
Page 44: Ian Seppelt: ICU in Review
Page 45: Ian Seppelt: ICU in Review

Nutrition in ICU

Page 46: Ian Seppelt: ICU in Review

Nutrition in ICU1.Core business of critical medicine

Page 47: Ian Seppelt: ICU in Review

Nutrition in ICU1.Core business of critical medicine2.We consistently deliver 2/3 of (prescribed)

target nutrition in first few days, up to 80-90% by a week– Are we just no good at it?– Or does it matter?

Page 48: Ian Seppelt: ICU in Review

Nutrition in ICU1.Core business of critical medicine2.We consistently deliver 2/3 of (prescribed)

target nutrition in first few days, up to 80-90% by a week– Are we just no good at it?– Or does it matter?

3.Targets of nutrition have never been validated in the critically ill– Anorexia and catabolism is a normal adaptive

stress response– Schofield and Harris-Benedict purely empirical

guesswork– Even calorimetry gives an energy consumption

Page 49: Ian Seppelt: ICU in Review

Nutrition in ICU

Page 50: Ian Seppelt: ICU in Review

Nutrition in ICU

Page 51: Ian Seppelt: ICU in Review

Nutrition in ICU

Page 52: Ian Seppelt: ICU in Review

Nutrition in ICU

Page 53: Ian Seppelt: ICU in Review

Nutrition – are the endpoints all wrong?

Page 54: Ian Seppelt: ICU in Review

Nutrition – are the endpoints all wrong?

Page 55: Ian Seppelt: ICU in Review

Nutrition – are the endpoints all wrong?

Page 56: Ian Seppelt: ICU in Review

Nutrition – are the endpoints all wrong?

Page 57: Ian Seppelt: ICU in Review

Traumatic Brain Injury

Page 58: Ian Seppelt: ICU in Review

Imaging and clinical examination

Page 59: Ian Seppelt: ICU in Review

Emerging infectious diseases

Page 60: Ian Seppelt: ICU in Review

Emerging infectious diseases

Page 61: Ian Seppelt: ICU in Review

Emerging infectious diseases

Page 62: Ian Seppelt: ICU in Review

Novel research responses

Page 63: Ian Seppelt: ICU in Review

Novel research responses

Page 64: Ian Seppelt: ICU in Review

Novel research responses

Page 65: Ian Seppelt: ICU in Review

[email protected]

Questions?


Top Related